価格表

在庫・価格 : 2026年04月18日 20時11分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
RANK Ligand/TNFSF11, Mouse, Recombinant <TRANCE>
データシート
462-TEC-010 RSDアールアンドディー システムズ
R&D Systems, Inc.
10 μg ¥71,000 3個以上 追加

在庫・価格 : 2026年04月18日 20時11分 現在

RANK Ligand/TNFSF11, Mouse, Recombinant <TRANCE>

  • 商品コード:462-TEC-010
  • メーカー:RSD
  • 包装:10μg
  • 価格: ¥71,000
  • 在庫:3個以上
使用文献
No. 文献情報 備考 参照
1 Ulrich-Vinther M et al. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002 Aug;84-A(8):1405-12
Ulrich-Vinther M et al
2002/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
2 Gartland A et al. Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice. Crit. Rev. Eukaryot. Gene Expr. 2003;13(2-4):243-53
Gartland A et al
2003/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Liao TS et al. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J. Orthop. Res. 2005 Jan;23(1):203-9
Liao TS et al
2005/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 de Vries TJ et al. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. J. Cell. Biochem. 2006 May;98(2):370-82
de Vries TJ et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Johansson MK et al. Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice. Blood 2007 Jun;109(12):5178-85
Johansson MK et al
2007/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
6 Liu D et al. A DNA microarray analysis of chemokine and receptor genes in the rat dental follicle--role of secreted frizzled-related protein-1 in osteoclastogenesis. Bone 2007 Aug;41(2):266-72
Liu D et al
2007/01/01
Species: Rat, Application: Bioassay, Sample type: Whole Cells PubMed
7 Tan SD et al. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption. Bone 2007 Nov;41(5):745-51
Tan SD et al
2007/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
8 Shivtiel S et al. CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules. J. Exp. Med. 2008 Sep;205(10):2381-95
Shivtiel S et al
2008/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
9 Binder NB et al. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat. Med. 2009 Apr;15(4):417-24
Binder NB et al
2009/01/01
Application: Bioassay,Flow Cytometry, Sample Type: Whole Cells PubMed
10 Kulkarni RN et al. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE. Calcif. Tissue Int. 2010 Nov;87(5):461-8
Kulkarni RN et al
2010/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
11 Fujiwara T et al. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am. J. Pathol. 2011 Sep;179(3):1157-70
Fujiwara T et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Muruganandan S et al. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells 2013 Oct;31(10):2172-82
Muruganandan S et al
2013/01/01
Application: Bioassay, Sample Type: whole cells PubMed
13 Sun Q et al. TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation. J. Bone Miner. Res. 2014 Jan;29(1):90-102
Sun Q et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Stalvey MS et al. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. PLoS ONE 2013;8(11):e80098
Stalvey MS et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
15 Tiwari M et al. A nonapoptotic role for CASP2/caspase 2: modulation of autophagy. Autophagy 2014 Jun;10(6):1054-70
Tiwari M et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
16 Schwarzer R et al. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model. Blood Cancer J 2014;4:e217
Schwarzer R et al
2014/01/01
Application: Bioassay, Sample Type: Cell culture PubMed
17 Abe T et al. Regulation of osteoclast homeostasis and inflammatory bone loss by MFG-E8. J. Immunol. 2014 Aug;193(3):1383-91
Abe T et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
18 Mediero A et al. Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiation. J. Bone Miner. Res. 2015 May;30(5):837-54
Mediero A et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
19 Zhang H et al. NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-&#x3BA;B. J. Clin. Invest. 2014 Jul;124(7):3200-14
Zhang H et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
20 Khor EC et al. Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome. PLoS ONE 2016;11(1):e0148155
Khor EC et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
21 Xiu Y et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J. Clin. Invest. 2014 Jan;124(1):297-310
Xiu Y et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
22 Fowler TW et al. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. J. Cell. Sci. 2015 Feb;128(4):683-94
Fowler TW et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
23 Beier EE et al. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/&#x3B2;-CATENIN SIGNALING PATHWAY. J. Biol. Chem. 2015 Jul;290(29):18216-26
Beier EE et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
24 Karlsson T et al. Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation. PLoS ONE 2016;11(11):e0166284
Karlsson T et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
25 Str奪lberg F et al. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors. J. Leukoc. Biol. 2017 May;101(5):1233-1243
Str奪lberg F et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
26 Browne AJ et al. Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer. Breast Cancer Res. 2017 Aug;19(1):92
Browne AJ et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Ulrich-Vinther M et al. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002 Aug;84-A(8):1405-12
    Ulrich-Vinther M et al
    2002/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Gartland A et al. Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice. Crit. Rev. Eukaryot. Gene Expr. 2003;13(2-4):243-53
    Gartland A et al
    2003/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Liao TS et al. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J. Orthop. Res. 2005 Jan;23(1):203-9
    Liao TS et al
    2005/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    de Vries TJ et al. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. J. Cell. Biochem. 2006 May;98(2):370-82
    de Vries TJ et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Johansson MK et al. Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice. Blood 2007 Jun;109(12):5178-85
    Johansson MK et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Liu D et al. A DNA microarray analysis of chemokine and receptor genes in the rat dental follicle--role of secreted frizzled-related protein-1 in osteoclastogenesis. Bone 2007 Aug;41(2):266-72
    Liu D et al
    2007/01/01
  • 備考:
    Species: Rat, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Tan SD et al. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption. Bone 2007 Nov;41(5):745-51
    Tan SD et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Shivtiel S et al. CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules. J. Exp. Med. 2008 Sep;205(10):2381-95
    Shivtiel S et al
    2008/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Binder NB et al. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat. Med. 2009 Apr;15(4):417-24
    Binder NB et al
    2009/01/01
  • 備考:
    Application: Bioassay,Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kulkarni RN et al. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE. Calcif. Tissue Int. 2010 Nov;87(5):461-8
    Kulkarni RN et al
    2010/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Fujiwara T et al. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am. J. Pathol. 2011 Sep;179(3):1157-70
    Fujiwara T et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Muruganandan S et al. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells 2013 Oct;31(10):2172-82
    Muruganandan S et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Sun Q et al. TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation. J. Bone Miner. Res. 2014 Jan;29(1):90-102
    Sun Q et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Stalvey MS et al. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. PLoS ONE 2013;8(11):e80098
    Stalvey MS et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Tiwari M et al. A nonapoptotic role for CASP2/caspase 2: modulation of autophagy. Autophagy 2014 Jun;10(6):1054-70
    Tiwari M et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Schwarzer R et al. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model. Blood Cancer J 2014;4:e217
    Schwarzer R et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Cell culture
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Abe T et al. Regulation of osteoclast homeostasis and inflammatory bone loss by MFG-E8. J. Immunol. 2014 Aug;193(3):1383-91
    Abe T et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Mediero A et al. Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiation. J. Bone Miner. Res. 2015 May;30(5):837-54
    Mediero A et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Zhang H et al. NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-&#x3BA;B. J. Clin. Invest. 2014 Jul;124(7):3200-14
    Zhang H et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Khor EC et al. Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome. PLoS ONE 2016;11(1):e0148155
    Khor EC et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Xiu Y et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J. Clin. Invest. 2014 Jan;124(1):297-310
    Xiu Y et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Fowler TW et al. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. J. Cell. Sci. 2015 Feb;128(4):683-94
    Fowler TW et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Beier EE et al. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/&#x3B2;-CATENIN SIGNALING PATHWAY. J. Biol. Chem. 2015 Jul;290(29):18216-26
    Beier EE et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Karlsson T et al. Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation. PLoS ONE 2016;11(11):e0166284
    Karlsson T et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Str奪lberg F et al. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors. J. Leukoc. Biol. 2017 May;101(5):1233-1243
    Str奪lberg F et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Browne AJ et al. Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer. Breast Cancer Res. 2017 Aug;19(1):92
    Browne AJ et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed